These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid). Zehentmayr F, Söhn M, Exeli AK, Wurstbauer K, Tröller A, Deutschmann H, Fastner G, Fussl C, Steininger P, Kranzinger M, Belka C, Studnicka M, Sedlmayer F. Radiat Oncol; 2015 May 28; 10():121. PubMed ID: 26018527 [Abstract] [Full Text] [Related]
5. Radical hypo-fractionated radiotherapy with volumetric modulated arc therapy in lung cancer : A retrospective study of elderly patients with stage III disease. Franceschini D, De Rose F, Cozzi L, Navarria P, Clerici E, Franzese C, Comito T, Tozzi A, Iftode C, D'Agostino G, Sorsetti M. Strahlenther Onkol; 2017 May 28; 193(5):385-391. PubMed ID: 28168322 [Abstract] [Full Text] [Related]
6. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience. Jiang ZQ, Yang K, Komaki R, Wei X, Tucker SL, Zhuang Y, Martel MK, Vedam S, Balter P, Zhu G, Gomez D, Lu C, Mohan R, Cox JD, Liao Z. Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):332-9. PubMed ID: 22079735 [Abstract] [Full Text] [Related]
13. Non-small cell lung cancer in stages I-IIIB: Long-term results of definitive radiotherapy with doses ≥ 80 Gy in standard fractionation. Wurstbauer K, Weise H, Deutschmann H, Kopp P, Merz F, Studnicka M, Nairz O, Sedlmayer F. Strahlenther Onkol; 2010 Oct 01; 186(10):551-7. PubMed ID: 20936459 [Abstract] [Full Text] [Related]
14. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Rosenzweig KE, Fox JL, Yorke E, Amols H, Jackson A, Rusch V, Kris MG, Ling CC, Leibel SA. Cancer; 2005 May 15; 103(10):2118-27. PubMed ID: 15830346 [Abstract] [Full Text] [Related]
20. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer. Feigenberg SJ, Hanlon AL, Langer C, Goldberg M, Nicolaou N, Millenson M, Coia LR, Lanciano R, Movsas B. J Thorac Oncol; 2007 Apr 15; 2(4):287-92. PubMed ID: 17409799 [Abstract] [Full Text] [Related] Page: [Next] [New Search]